Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03390361
Other study ID # Femto IL + PG Study
Secondary ID
Status Completed
Phase N/A
First received December 28, 2017
Last updated January 4, 2018
Start date April 5, 2016
Est. completion date November 25, 2016

Study information

Verified date January 2018
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with bilateral age related cataract will be included in the study. Manual cataract surgery (MCS) will be performed in one eye and laser cataract surgery (LCS) in the corresponding eye. LCS will be performed with an approved femtosecond laser (FSL) device with an integrated imaging system.

After surgery aqueous humour will be collected and screened with Enzyme-linked Immunosorbent Assay (ELISA) Kits for Interleukin-1β; Interleukin-6 and PG.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date November 25, 2016
Est. primary completion date August 9, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Bilateral age-related cataract necessitating phacoemulsification extraction and posterior intraocular lens implantation.

- Pupil dilation of = 6.5mm

- Age 40 and older

Exclusion Criteria:

- Corneal abnormality

- Pseudoexfoliation

- Preceding ocular surgery or trauma

- Uncontrolled glaucoma

- Proliferative diabetic retinopathy

- Iris neovascularization

- History of uveitis/iritis

- Microphthalmus

- Recurrent intraocular inflammation of unknown etiology

- Blind fellow eye

- Uncontrolled systemic or ocular disease

- Pregnancy

- Lactation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Femtosecond Laser-assisted
Laser cataract surgery will be performed in one eye
Procedure:
Manual Cataract Surgery
Manual cataract surgery will be performed in contralateral eye

Locations

Country Name City State
Austria Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proinflammatory cytokines (IL-1ß, IL-6) and total-PG Interleukin IL-1ß, Interleukin IL-6, total-prostaglandin 5 minutes after laser procedure
See also
  Status Clinical Trial Phase
Recruiting NCT06053554 - Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome N/A
Completed NCT03903965 - Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
Completed NCT04196673 - Posterior Capsule Opafication of Two Different Hydrophobic Acrylic Intraocular Lenses N/A
Active, not recruiting NCT03390400 - Changes in Prostaglandin Levels in Laser Cataract Surgery (LCS) Subject to Laser Prevalence N/A
Recruiting NCT03525015 - Impact of a Printed Decision Aid on Cataract Surgery Choice N/A
Active, not recruiting NCT03465124 - Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery N/A
Not yet recruiting NCT04230629 - Evaluation of Physiological Responses at the Anterior Surface of Two (Hydrophobic Acrylic) Intraocular Lens Models N/A
Recruiting NCT04321226 - Femtosecond Laser-assisted Astigmatism Treatment Phase 4
Recruiting NCT03803852 - Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric N/A
Active, not recruiting NCT04369482 - Posterior Capsule Opafication of Different Hydrophobic Acrylic Intraocular Lenses: Vivinex iSert P261 vs.Clareon IOL N/A
Completed NCT06365762 - The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract Phase 1/Phase 2
Recruiting NCT05822089 - Intraindividual Comparison of EMO IOLs N/A